An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies
K Iffland, F Grotenhermen - Cannabis and cannabinoid research, 2017 - liebertpub.com
Introduction: This literature survey aims to extend the comprehensive survey performed by
Bergamaschi et al. in 2011 on cannabidiol (CBD) safety and side effects. Apart from …
Bergamaschi et al. in 2011 on cannabidiol (CBD) safety and side effects. Apart from …
[HTML][HTML] Clinicians' guide to cannabidiol and hemp oils
HJ VanDolah, BA Bauer, KF Mauck - Mayo Clinic Proceedings, 2019 - Elsevier
Cannabidiol (CBD) oils are low tetrahydrocannabinol products derived from Cannabis sativa
that have become very popular over the past few years. Patients report relief for a variety of …
that have become very popular over the past few years. Patients report relief for a variety of …
[HTML][HTML] Medicinal cannabis: history, pharmacology, and implications for the acute care setting
MB Bridgeman, DT Abazia - Pharmacy and therapeutics, 2017 - ncbi.nlm.nih.gov
Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Cannabidiol (CBD) use in psychiatric disorders: A systematic review
S Bonaccorso, A Ricciardi, C Zangani, S Chiappini… - Neurotoxicology, 2019 - Elsevier
Abstract Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) are the most represented
phytocannabinoids in Cannabis sativa plants. However, CBD may present with a different …
phytocannabinoids in Cannabis sativa plants. However, CBD may present with a different …
Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches
V Raj, JG Park, KH Cho, P Choi, T Kim, J Ham… - International journal of …, 2021 - Elsevier
Effective treatment choices to the severe acute respiratory syndrome coronavirus-2 (SARS-
CoV-2) are limited because of the absence of effective target-based therapeutics. The main …
CoV-2) are limited because of the absence of effective target-based therapeutics. The main …
European Pain Federation (EFIC) position paper on appropriate use of cannabis‐based medicines and medical cannabis for chronic pain management
W Häuser, DP Finn, E Kalso… - … Journal of Pain, 2018 - Wiley Online Library
Cannabis‐based medicines are being approved for pain management in an increasing
number of European countries. There are uncertainties and controversies on the role and …
number of European countries. There are uncertainties and controversies on the role and …
An overview on medicinal chemistry of synthetic and natural derivatives of cannabidiol
P Morales, PH Reggio, N Jagerovic - Frontiers in pharmacology, 2017 - frontiersin.org
Cannabidiol (CBD) has been traditionally used in Cannabis-based preparation, however
historically, it has received far less interest as a single drug than the other components of …
historically, it has received far less interest as a single drug than the other components of …
Mucoadhesive nanostructured lipid carriers as a cannabidiol nasal delivery system for the treatment of neuropathic pain
AP Matarazzo, LMS Elisei, FC Carvalho… - European Journal of …, 2021 - Elsevier
The therapeutic potential of cannabidiol (CBD) has been explored to treat several
pathologies, including those in which pain is prevalent. However, the oral bioavailability of …
pathologies, including those in which pain is prevalent. However, the oral bioavailability of …
Low-dose cannabidiol is safe but not effective in the treatment for Crohn's disease, a randomized controlled trial
T Naftali, R Mechulam, A Marii, G Gabay… - Digestive diseases and …, 2017 - Springer
Background Cannabidiol (CBD) is an anti-inflammatory cannabinoid shown to be beneficial
in a mouse model of IBD. Lacking any central effect, cannabidiol is an attractive option for …
in a mouse model of IBD. Lacking any central effect, cannabidiol is an attractive option for …
Future aspects for cannabinoids in breast cancer therapy
T Kisková, F Mungenast, M Suváková, W Jäger… - International journal of …, 2019 - mdpi.com
Cannabinoids (CBs) from Cannabis sativa provide relief for tumor-associated symptoms
(including nausea, anorexia, and neuropathic pain) in the palliative treatment of cancer …
(including nausea, anorexia, and neuropathic pain) in the palliative treatment of cancer …